Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

A Novel Plasma Panel for the Assessment of Chronic Liver Disease Severity

Clayton S Lewis, PhD, Marc Vasse, Professor, Patrick Van Dreden, PhD, Vladimir Y Bogdanov, PhD

Blood (2018) 132 (Supplement 1): 3784.

https://doi.org/10.1182/blood-2018-99-114906

Published: 2018

Journal Articles

Alternatively Spliced Tissue Factor Levels in the Plasma of Patients with Liver Fibrosis, Liver Cirrhosis, and Hepatocellular Carcinoma: A Single-Center Retrospective Study

Nathalie Caversaccio, Raja Prince, Sara Calzavarini, PhD, Maria Desiré Reina Caro, Clayton s Lewis, Vladimir Bogdanov, PhD, Jean-Francois Dufour, Anne Angelillo-Scherrer

Blood (2017) 130 (Supplement 1): 3701.

https://doi.org/10.1182/blood.V130.Suppl_1.3701.3701

Published: 2017

Journal Articles

SGN-CD48A: a Novel Humanized Anti-CD48 Antibody-Drug Conjugate for the Treatment of Multiple Myeloma

Tim S. Lewis, PhD, Devra Olson, B.S., Kristine Gordon, B.S., Sharsti Sandall, PhD, Marsha Quick, B.S., Margo Finn, B.S., Lori Westendorf, B.S., Germein Linares, B.S., Chris Leiske, B.S., Albina Nesterova, B.S., Lanshan Huang, B.S., Maitrayee Goswami, B.S., Sa Wang, MD, Che-Leung Law, PhD

Blood (2016) 128 (22): 4470.

https://doi.org/10.1182/blood.V128.22.4470.4470

Published: 2016

Journal Articles

Preclinical Analysis of the Combined Activity of SGN-40, Anti-CD40 Monoclonal Antibody, with Rituximab in Non-Hodgkin Lymphoma.

Timothy S. Lewis, Renee S. McCormick, Julie A. McEarchern, Kim Kissler, Ivan J. Stone, Hans-Peter Gerber, Jonathan G. Drachman, Iqbal Grewal, Che-Leung Law

Blood (2008) 112 (11): 1583.

https://doi.org/10.1182/blood.V112.11.1583.1583

Published: 2008

Journal Articles

The Humanized Anti-CD40 Monoclonal Antibody, SGN-40, Potentiates Chemotherapy Regimens in NHL Xenograft Models Via Pro-Apoptotic Signaling.

Timothy S. Lewis, PhD, Renee S. McCormick, B.S., Kim Kissler, B.S., Ivan J. Stone, B.S., Mechthild Jonas, Ph.D., May S.K. Sutherland, Ph.D., Hans-Peter Gerber, Ph.D., Jonathan G. Drachman, M.D., Iqbal S. Grewal, Ph.D., Che-Leung Law, Ph.D.

Blood (2007) 110 (11): 2342.

https://doi.org/10.1182/blood.V110.11.2342.2342

Published: 2007

Journal Articles

SGN-33, Lintuzumab, Demonstrates Anti-Leukemic Activity in Preclinical Models of AML.

May S.K. Sutherland, PhD, Changpu Yu, MD, Carol Morris-Tilden, Timothy S. Lewis, PhD, Jamie B. Miyamoto, Julie A. McEarchern, PhD, Ezogelin Oflazoglu, PhD, Hanspeter Gerber, PhD, Eric L. Sievers, MD, Iqbal S. Grewal, PhD, Che-Leung Law, PhD

Blood (2007) 110 (11): 919.

https://doi.org/10.1182/blood.V110.11.919.919

Published: 2007

Journal Articles

SGN-33 Modulates Cytokine and Chemokine Production by Activated Monocytes and Macrophages.

May S.K. Sutherland, PhD, Timothy S. Lewis, PhD, Changpu Yu, MD, Julie A. McEarchern, PhD, Jonathan G. Drachman, MD, Eric L. Sievers, MD, Iqbal S. Grewal, PhD, Che-Leung Law, PhD

Blood (2006) 108 (11): 1995.

https://doi.org/10.1182/blood.V108.11.1995.1995

Published: 2006

Journal Articles

The Humanized Anti-CD40 Antibody, SGN-40, Promotes Apoptosis Signaling and Is Effective in Combination with Standard Therapies in Lymphoma Xenograft Models.

Timothy S. Lewis, PhD, May S.K. Sutherland, Ph.D., Mechthild Jonas, Ph.D., Charles G. Cerveny, M.S., Renee McCormick, B.S., Alan F. Wahl, Ph.D., Jonathan G. Drachman, M.D., Iqbal S. Grewal, Ph.D., Che-Leung Law, Ph.D.

Blood (2006) 108 (11): 2499.

https://doi.org/10.1182/blood.V108.11.2499.2499

Published: 2006

Journal Articles

Global Haemostasis in Critically Ill Patients with Sepsis: Evidence for a Prothrombotic State.

P. Collins, S. Lewis, N. Macartney, E. Stephenson, R. Davies, S. Lees, A. Saayman, L. Macchiavello, G. Findlay

Blood (2005) 106 (11): 2140.

https://doi.org/10.1182/blood.V106.11.2140.2140

Published: 2005

Journal Articles

The 5q-syndrome

J Boultwood, S Lewis, JS Wainscoat

Blood (1994) 84 (10): 3253–3260.

https://doi.org/10.1182/blood.V84.10.3253.3253

Published: 1994

Journal Articles

Allelic loss of IRF1 in myelodysplasia and acute myeloid leukemia: retention of IRF1 on the 5q- chromosome in some patients with the 5q- syndrome

J Boultwood, C Fidler, S Lewis, A MacCarthy, H Sheridan, S Kelly, D Oscier, VJ Buckle, JS Wainscoat

Blood (1993) 82 (9): 2611–2616.

https://doi.org/10.1182/blood.V82.9.2611.2611

Published: 1993

NARROW

A Novel Plasma Panel for the Assessment of Chronic Liver Disease Severity

Alternatively Spliced Tissue Factor Levels in the Plasma of Patients with Liver Fibrosis, Liver Cirrhosis, and Hepatocellular Carcinoma: A Single-Center Retrospective Study

SGN-CD48A: a Novel Humanized Anti-CD48 Antibody-Drug Conjugate for the Treatment of Multiple Myeloma

Preclinical Analysis of the Combined Activity of SGN-40, Anti-CD40 Monoclonal Antibody, with Rituximab in Non-Hodgkin Lymphoma.

The Humanized Anti-CD40 Monoclonal Antibody, SGN-40, Potentiates Chemotherapy Regimens in NHL Xenograft Models Via Pro-Apoptotic Signaling.

SGN-33, Lintuzumab, Demonstrates Anti-Leukemic Activity in Preclinical Models of AML.

SGN-33 Modulates Cytokine and Chemokine Production by Activated Monocytes and Macrophages.

The Humanized Anti-CD40 Antibody, SGN-40, Promotes Apoptosis Signaling and Is Effective in Combination with Standard Therapies in Lymphoma Xenograft Models.

Global Haemostasis in Critically Ill Patients with Sepsis: Evidence for a Prothrombotic State.

The 5q-syndrome

Allelic loss of IRF1 in myelodysplasia and acute myeloid leukemia: retention of IRF1 on the 5q- chromosome in some patients with the 5q- syndrome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only